Advantages and Limitations of Commonly Used Nonhuman Primate Species in Research and Development of Biopharmaceuticals

The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment · 2015 · PMC7149394

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

The only finding associated with canakinumab treatment was a slight reduction in the number of fetuses at the high dose, which correlated with a slight trend toward decreased placental weight.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.